Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a licensing agreement with Neopharm Israel for the exclusive rights to commercialize NEXLETOL ® (bempedoic acid) and NEXLIZET ® ...
Itching of the skin, also called pruritus, is a common problem experienced by many people. The itching may or may not come along with a rash, which can be limited to small areas of skin or can occur ...
A sun rash can occur due to a genetic condition or the use of a certain medication. The rash may appear as small blisters and cause an itching or burning feeling, among other symptoms. Sun rash is ...
Urticaria may present with superficial swellings of the dermis called wheals or deeper swellings of the dermis, subcutaneous, or submucosal tissues known as angioedema. Wheals are typically itchy ...
Incyte’s $750 million buyout of Escient Pharmaceuticals is in a rough patch as a mid-stage chronic hives candidate was flagged with safety … ...
The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for dupilumab for the treatment of chronic spontaneous urticaria (CSU ...